bioMerieux planning IPO

As expected, diagnostics company bioMerieux announced IPO plans that will enable long-time shareholder Wendel Investissement to sell its 35% holding. The French private equity group recently said it wanted to exit. Under the planned IPO on the Premier Marche of Euronext Paris, Wendel will offer 10 million bioMerieux shares at EUR 26.90-EUR 31.25 through bookrunners Galyon and Goldman Sachs. Wendel also will offer up to 1.5 million shares to cover overallotments. ...